The pathway for processing leader-derived peptides that regulate the maturation and expression of Qa-1b

Immunity

Volumn 9, Issue 3, 1998, Pages 413-421

  Bai, Ailin ^a,b,c   Broen, James ^a,c   Forman, James ^a,c  

^a Department of Microbiology ^*  (United States)

^b Univ of Texas SW Medical Center   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME INHIBITOR; EPITOPE; HLA E ANTIGEN; LACTACYSTIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PEPTIDE; PEPTIDE QA 1B; PROTEASOME; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; CONTROLLED STUDY; CYTOSOL; CYTOTOXIC T LYMPHOCYTE; ENDOPLASMIC RETICULUM; FLOW CYTOMETRY; HELA CELL; HERPES VIRUS; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROCESSING; PROTEIN TRANSPORT; VACCINIA VIRUS; VIRUS INFECTION;

EID: 0032169755     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80624-X     Document Type: Article

References (55)

1. Ahn, K., Meyer, T.H., Uebel, S., Sempe, P., Djaballah, H., Yang, Y., Peterson, P.A., Fruh, K., and Tampe, R. (1996). Molecular mechanism and species specificity of TAP inhibition by herpes simplex virus protein ICP-47. EMBOJ. 15, 3247-3255.
2. Aldrich, C.J., DeCloux, A., Woods, A.S., Cotter, R.J., Soloski, M.J., and Forman, J. (1994). Identification of TAP-dependent leader peptide recognized by alloreactive T cells specific for a class Ib antigen. Cell 79, 649-658.
3. Bacik, I., Snyder, H.L., Anton, L.C., Russ, G., Chen, W., Bennink, J.R., Urge, L., Otvos, L., Dudkowska, B., Eisenlohr, L., et al. (1997). Introduction of aglycosylation site into a secreted protein provides evidence for an alternative antigen processing pathway: transport of precursors of major histocompatibility complex class I-restricted peptides from the endoplasmic reticulum to the cytosol. J. Exp. Med. 186, 479-487.
4. Bai, A., and Forman, J. (1997). The effect of the proteasome inhibitor lactacystin on the presentation of transporter associated with antigen processing (TAP)-dependent and TAP-independent peptide epitopes by class I molecules. J. Immunol. 159, 2139-2146.
5. Borrego, F., Ulbrencht, M., Weiss, E.H., Coligan, J.E., and Brooks, A.G. (1998). Recognition of HLA-Ecomplexed with HLAclass I signal sequence-derived peptides by CD94/NKG2 confers protection from NK cell mediated lysis. J. Exp. Med. 187, 813-818.
6. Braud, V.M., Allan, D.S.J., Wilson, D., and McMichael, A.J. (1998a). TAP- and tapasin-dependent HLA-E surface expression correlates with the binding of an MHC class I leader peptide. Curr. Biol. 8, 1-10.
7. Braud, V.M., Allan, D.S.J., O'Callghan, C.A., Soderstrom, K., D'Andrea, A., Ogg, G.S., Lazetic, S., Young, N.T., Bell, J.I., Phillips, J.H., et al. (1998b). HLA-E binds to natural killer cell receptors CD94/ NKG2A, B and C. Nature 391, 795-799.
8. Cerundolo, V., Benham, A., Braud, V., Mukherjee, S., Gould, K., Macino, B., Neefjes, J., and Townsend, A. (1997). The proteasome-specific inhibitor lactacystin blocks presentation of cytotoxic T lymphocyte epitopes in human and murine cells. Eur. J. Immunol. 27, 336-341.
9. Cotterill, L.A., Stauss, H.J., Millrain, M.M., Pappin, D.J.C., Rahman, D., Canas, B., Chandle, P., Stackpoole, A., Simpson, E., Robinson, P.J., et al. (1997). Qa-1 interaction and T cell recognition of the Qa-1 determinant modifier peptide. Eur. J. Immunol. 27, 2123-2132.
10. b. J. Immunol. 158, 2183-2191.
11. Elliott, T., Willis, A., Cerundolo, V., and Townsend, A. (1995). Processing of major histocompatibility class I-restricted antigens in the endoplasmic reticulum. J. Exp. Med. 181, 1481-1491.
12. Ferris, R.L., Buck, C., Hammond, S.A., Woods, A.S., Cotter, R.J., Takiguchi, M., Igarashi, Y., Ichikawa, Y., and Siliciano, R.F. (1996). Class I-restricted presentation of an HIV-1 gp41 epitope containing an N-linked glycosylation site. Implications for the mechanism of processing of viral envelope proteins. J. Immunol. 156, 834-840.
13. Fruh, K., Ahn, K., Djaballah, H., Sempe, P., van Endert, P.M., Tampe, R., Peterson, P.A., and Yang, Y. (1995). A viral inhibitor of peptide transporters for antigen presentation. Nature 375, 415-418.
14. Glas, R., Bogyo, M., McMaster, J.S., Gaczynska, M., and Ploegh, H.L. (1998). A proteolytic system that compensates for loss of proteasome function. Nature 392, 618-622.
15. Goldberg, A.L., and Rock, K.L. (1992). Proteolysis, proteasome, and antigen presentation. Nature 357, 375-379.
16. Grandea, A.G., Androlewicz, M.J., Athwal, R.S., Geraghty, D.E., and Spies, T. (1995). Dependence of peptide binding by MHC class I molecules on their interaction with TAP. Science 270, 105-108.
17. + T cells. Nature 364, 158-161.
18. + CTL. J. Immunol. 154, 6140-6156.
19. Heemels, M.-T., and Ploegh, H.L. (1995). Generation, translocation, and presentation of MHC class-I restricted peptides. Annu. Rev. Biochem. 64, 463-491.
20. Henderson, R.A., Michel, H., Sakaguchi, K., Shabanowitz, J., Appella, E., Hunt, D.F., and Engelhard, V.H. (1992). HLA-A2.1-associated peptides from a mutant cell line: a second pathway of antigen presentation. Science 255, 1264-1266.
21. Hill, A., Jugovic, P., York, I., Russ, G., Bennink, J., Yewdell, J., Ploegh, H., and Johnson, D. (1995). Herpes simplex virus turns off the TAP to evade host immunity. Nature 375, 411-415.
22. Ho, S.N., Hunt, H.D., Horton, R.M., Pullen, J.K., and Pease, L.R. (1989). Site directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77, 51-59.
23. Hombach, J., Pircher, H., Tonegawa, S., and Zinkernagel, R.M. (1995). Strictly transporter of antigen presentation (TAP)-dependent presentation of an immunodominant cytotoxic T lymphocyte epitope in the signal sequence of a viral protein. J. Exp. Med. 182, 1615-1619.
24. Howard, J.C. (1995). Supply and transport of peptides presented by class I MHC molecules. Curr. Opin. Immunol. 7, 69-76.
25. Inouye, S., Soberon, X., Franceschini, T., Nakamura, K., Itakura, K., and Inouye, M. (1982). Role of positive charge on the amino-terminal region of the signal peptide in protein secretion across the membrane. Proc. Natl. Acad. Sci. USA 79, 3438-3441.
26. Izard, J.W., and Kendall, D.A. (1994). Signal peptides: exquisitely designed transport promoters. Mol. Microbiol. 13, 765-773.
27. Lanier, L.L. (1997). Natural killer cells: from no receptors to too many. Immunity 6, 371-378.
28. Lee, S.P., Thomas, W.A., Blake, N.W., and Rickinson, A.B. (1996). Transporter (TAP)-independent processing of amultiple membrane-spanning protein, the Epstein-Barr virus latent membrane protein 2. Eur. J. Immunol. 26, 1875-1883.
29. Ljunggren, H.-G., and Karre, K. (1990). In search of the "missing self": MHC molecules and NK cell recognition. Immunol. Today 11, 237-244.
30. Lowen, L.C., Aldrich, C.J., and Forman, J. (1993). Analysis of T cell receptors specific for recognition of class Ib antigens. J. Immunol. 151, 6155-6165.
31. Luckey, C.J., King, G.M., Marto, J.A., Venketeswaran, S., Maier, B.F., Crotzer, V.L. Shabanowitz, J., Hunt, D.F., and Engelhard, V.H. (1998). Proteasomes can either generate or destroy MHC class I epitopes: evidence for nonproteasomal epitope generation in the cytosol. J. Immunol. 161, 112-121.
32. Lyko, F., Martoglio, B., Jungnickel, B., Rapoport, T.A., and Dobberstein, B. (1995). Signal sequence processing in rough microsomes. J. Biol. Chem. 270, 19873-19878.
33. Mackett, M., Smith, G.L., and Moss, B. (1985). The construction and characterization of vaccinia virus recombinants expressing foreign genes. In DNA Cloning: a Practical Approach. D.M. Glover, ed. (Oxford: IRL Press), pp. 191-211.
34. Martoglio, B., Graf, R., and Dobberstein, B. (1997). Signal peptide fragments of preprolactin and HIV-1 p-gp160 interact with calmodulin. EMBO J. 22, 6636-6645.
35. Mosse, C.A., Meadows, L., Luckey, C.J., Kittlesen, D.J., Huczko, E.L., Slingluff, C.L., Jr., Shabanowitz, J., Hunt, D.F., and Engelhard, V.H. (1998). The class I antigen-processing pathway for the membrane protein tyrosinase Involves translation in the endoplasmic reticulum and processing in the cytosol. J. Exp. Med. 187, 37-48.
36. Neefjes, J.J., Morburg, F., and Hammmerling, G.J. (1993). Selective and ATP-dependenttranslocation of peptides by the MHC-encoded transporter. Science 261, 769-771.
37. Niedermann, G., Butz, S., Ihlenfeldt, H.G., Grimm, R., Lucchiari, M., Hoschutzky, H., Jung, G., Maier, B., and Eichmann, K. (1995). Contribution of proteasome-mediated proteolysis to the hierarchy of epitopes presented by major histocompatibility complex class I molecules. Immunity 2, 289-299.
38. Nielsen, H., Engelbrech, J., Brunak, S., and von Heijne, G. (1997). Identification of prokaryoticand eukaryotic signal peptides and prediction of their cleavage sites. Pro. Engineering 10, 1-6.
39. Roelse, J., Gramme, M., Momburg, F., Hammerling, G., and Neefjes, J. (1994). Trimming of TAP-translocated peptides in the endoplasmic reticulum and in the cytosol during recycling. J. Exp. Med. 180, 1591-1597.
40. Sadasivan, B., Lehner, P.J., Ortmann, B., Spies, T., and Cresswell, P. (1996). Roles of calreticulin and a novel glycoprotein, tapasin, in the interaction of MHC class I molecules with TAP. Immunity 5, 103-114.
41. Shen, L.M., Lee, J.-I., Cheng, S., Jutte, H., Kuhn, A., and Dalbey, R.E. (1991). Use of site-directed mutagenesis to define the limits of sequence variation tolerated for processing of the M13 procoat protein by the Escherichia coli leader peptidase. Biochemistry 30, 11775-11781.
42. Shepherd, J.C., Schumacher, T.N.M., Ashton-Rickardt, P.G., Imaeda, S., Ploegh, H.L. Janeway, C.A., and Tonegawa, S. (1993). TAP1-dependent peptide translocation in vitro is ATP dependent and peptide selective. Cell 74, 577-584.
43. Snyder, H.L., Yewdell, J.W., and Bennink, J.R. (1994). Trimming of antigenic peptides in an early secretory compartment. J. Exp. Med. 180, 2389-2394.
44. Snyder, H.L., Bacik, I., Bennink, J.R., Kearns, G., Behrens, T.W., Bachi, T., Orlowski, M., and Yewdell, J.W. (1997). Two novel routes of transporter associated with antigen processing (TAP)-independent major histocompatibility complex class I antigen processing. J. Exp. Med. 186, 1087-1098.
45. Suh, W., Cohen-Doyle, M.F., Froh, K., Wang, K., Peterson, P.A., and Williams, D.B. (1994). Interaction of MHC class I molecules with the transporter associated with antigen processing. Science 264, 1322-1326.
46. Takebe, Y., Seiki, M., Fujisawa, J., Hoy, P., Yokota, K., Aral, K., Yoshida, M., and Arai, N. (1988). Srα promoter: an efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat. Mol. Cell. Biol. 8, 4466-4472.
47. Tobery, T.W., and Siliciano, R.F. (1997). Targeting of HIV-1 antigen for rapid intracellular degradation enhance cytotoxic T lymphocyte (CTL) recognition and the induction of de novo CTL responses in vivo after immunization. J. Exp. Med. 185, 909-920.
48. Tomazin, R., Hill, A.B., Jugovic, P., York, I., van Endert, P., Ploegh, H.L., Andrews, D.W., and Johnson, D.C. (1996). Stable binding of the herpes simplex virus ICP-47 protein to the peptide binding site of TAP. EMBO J. 3256-3266.
49. b signal sequence requires the transporter-associated with antigen presentation. J. Immunol. 158, 685-692.
50. Vinitsky, A., Anton, L.C., Snyder, H.L., Orlowski, M., Bennink, J.R., and Yewdell, J.W. (1997). The generation of MHC class I-associated peptides is only partially inhibited by proteasome inhibitors: involvement of nonproteasomal cytosolic proteases in antigen processing? J. Immunol. 159, 554-564.
51. von Heijne, G. (1985). Signal sequences: the limits of variation. J. Mol. Biol. 184, 99-105.
52. Wei, M.L., and Cresswell, P. (1992). HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides. Nature 356, 443-446.
53. 1H nuclear magnetic resonance studies of synthetic peptides. Biochemistry 29, 8998-9006.
54. Yellen-Shaw, A.J., Wherry, E.J., Dubois, G.C., and Eisenlohr, L.C. (1997). Point mutation flanking a CTL epitope ablates in vitro and in vivo recognition of a full-length viral protein. J. Immunol. 158, 3227-3234.
55. York, I.A., and Rock, K.L. (1996). Antigen processing and presentation by class I major histocompatibility complex. Annu. Rev. Immunol. 14, 369-396.